Suppr超能文献

正交组合 CRISPR 筛选的优化指标。

Optimized metrics for orthogonal combinatorial CRISPR screens.

机构信息

Institute of Biochemistry II, Faculty of Medicine, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Helmholtz-Centre for Infection Research (HZI), Helmholtz Institute for RNA-Based Infection Research (HIRI), 97080, Würzburg, Germany.

出版信息

Sci Rep. 2023 May 6;13(1):7405. doi: 10.1038/s41598-023-34597-8.

Abstract

CRISPR-based gene perturbation enables unbiased investigations of single and combinatorial genotype-to-phenotype associations. In light of efforts to map combinatorial gene dependencies at scale, choosing an efficient and robust CRISPR-associated (Cas) nuclease is of utmost importance. Even though SpCas9 and AsCas12a are widely used for single, combinatorial, and orthogonal screenings, side-by-side comparisons remain sparse. Here, we systematically compared combinatorial SpCas9, AsCas12a, and CHyMErA in hTERT-immortalized retinal pigment epithelial cells and extracted performance-critical parameters for combinatorial and orthogonal CRISPR screens. Our analyses identified SpCas9 to be superior to enhanced and optimized AsCas12a, with CHyMErA being largely inactive in the tested conditions. Since AsCas12a contains RNA processing activity, we used arrayed dual-gRNAs to improve AsCas12a and CHyMErA applications. While this negatively influenced the effect size range of combinatorial AsCas12a applications, it enhanced the performance of CHyMErA. This improved performance, however, was limited to AsCas12a dual-gRNAs, as SpCas9 gRNAs remained largely inactive. To avoid the use of hybrid gRNAs for orthogonal applications, we engineered the multiplex SpCas9-enAsCas12a approach (multiSPAS) that avoids RNA processing for efficient orthogonal gene editing.

摘要

基于 CRISPR 的基因干扰可实现对单一和组合基因型-表型关联的无偏研究。鉴于大规模绘制组合基因依赖性的努力,选择一种高效且稳健的 CRISPR 相关(Cas)核酸酶至关重要。尽管 SpCas9 和 AsCas12a 广泛用于单一、组合和正交筛选,但并排比较仍然很少。在这里,我们系统地比较了组合 SpCas9、AsCas12a 和 CHyMErA 在永生化视网膜色素上皮细胞中的性能,并提取了组合和正交 CRISPR 筛选的关键性能参数。我们的分析表明,SpCas9 优于增强和优化的 AsCas12a,而在测试条件下,CHyMErA 基本上没有活性。由于 AsCas12a 含有 RNA 处理活性,我们使用阵列双 gRNA 来改进 AsCas12a 和 CHyMErA 的应用。虽然这对组合 AsCas12a 应用的效果大小范围产生了负面影响,但它增强了 CHyMErA 的性能。然而,这种改进的性能仅限于 AsCas12a 双 gRNA,因为 SpCas9 gRNA 仍然基本没有活性。为了避免使用杂交 gRNA 进行正交应用,我们设计了多路复用 SpCas9-enAsCas12a 方法(multiSPAS),该方法避免了 RNA 处理,从而实现了高效的正交基因编辑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a37d/10164157/00f2e0f31460/41598_2023_34597_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验